Home>Topics>Companies>Quest Diagnostics

Quest Diagnostics DGX

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
    1. Bloody Disruption: New Threat To Quest , LabCorp

      Headlines

      Mon, 23 Jun 2014

      frequency of medical testing; or a 30-year old vegan and college dropout with some famous friends? If you’re Quest Diagnostics ( DGX ) and Laboratory Corp. of America ( LH ), it may be the dropout, named Elizabeth Holmes, who left Stanford

    2. Quest to offer Sequenom fetal DNA test

      Headlines

      Mon, 16 Jun 2014

      Sequenom ( SQNM +10.1% ) and Quest Diagnostics ( DGX -0.1% ) sign a two-year agreement where DGX will offer SQNM's MaterniT21 PLUS laboratory ..... on an exclusive nation-wide basis. DGX will pay SQNM an undisclosed fixed fee

    3. Raising Fair Value on Sonic Healthcare to Reflect Growing Offshore Presence

      Commentary

      Wed, 11 Jun 2014

      are reimbursed under Medicare and Medicaid respectively. In the U.S., Sonic remains a minnow compared with Quest Diagnostics and LabCorp, with a market share of about 1.5% versus 15%. The U.S. market remains attractive given expected

    4. Top 10 Purchases and Sales from Our Ultimate Stock-Pickers

      Headlines

      Tue, 3 Jun 2014

      was with Oakmark Equity & Income's elimination of Quest Diagnostics DGX "> DGX . Clyde McGregor noted the following in his ..... and three that didn’t (Encana, Hospira and Quest Diagnostics )... In the case of Encana and Quest Diagnostics

    5. The Best Dividend Growers, Part 15: Quest Diagnostics

      Headlines

      Wed, 28 May 2014

      Laboratory of America ( LH ) Quest Diagnostics ( DGX ) Tenet Healthcare ( THC ..... the order is as follows: Quest Diagnostics - 2.29% Patterson Companies ..... the order is as follows: Quest Diagnostics - 230% Patterson Companies

    6. LabCorp's First-Quarter Volume Was Solid, but Pricing Took a Hit

      Commentary

      Mon, 28 Apr 2014

      molecular pathology codes and sequestration. As with Quest Diagnostics , we anticipate the pressure should lift somewhat now ..... believe this sets LabCorp apart from its largest rival Quest . LabCorp is on the cusp of rolling out its Beacon LBS

    7. Quest Diagnostics Posts Anemic 1Q, and Our Fair Value Estimate Is Unchanged

      Commentary

      Thu, 24 Apr 2014

      Quest Diagnostics posted tepid first-quarter performance ..... the quarter to change our thinking on Quest 's narrow economic moat. Although the ..... these slightly more positive trends, Quest 's operating margin fell yet again

    8. Oakmark Equity and Income Fund Letter to Shareholders

      Headlines

      Tue, 8 Apr 2014

      t (Encana, Hospira and Quest Diagnostics ). Cimarex and Concho are oil and gas ..... position. In the case of Encana and Quest Diagnostics , fundamental underperformance ..... redeploy the money elsewhere. With Quest , its weakening market share and tougher

    9. New Morningstar Analyst Report for Laboratory Corporation of America Holdings

      Stock Reports

      Fri, 4 Apr 2014

      with a larger out-of-pocket burden, which could become a perennial drag on growth in diagnostics. Like rival Quest Diagnostics , a substantial chunk of LabCorp's sales are reimbursed by Medicare, which leaves the firms vulnerable to increased

    10. Myriad Settles Patent Infringement Lawsuit with Gene by Gene

      Commentary

      Fri, 7 Feb 2014

      revealed in the remaining patent infringement cases it is involved in. These include lawsuits with Ambry Genetics, Quest Diagnostics , and LabCorp, all of which have greater resources at their disposal than Gene by Gene, in our opinion.

    « Prev12345Next »
    Content Partners